Trial Profile
A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 14 Jun 2019 Status changed from recruiting to completed.
- 02 Jun 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record